Tachyon is a cutting-edge point-of-care molecular diagnostics device that integrates nanopore sequencing with real-time gene expression analysis.
15x faster, 2x cheaper. By delivering real-time results directly at the point of care and eliminating the need for off-site processing or specialised bioinformatics expertise, Tachyon reduces diagnostic turnaround times from weeks to under 24 hours. This innovation positions us at the forefront of precision medicine, offering significant value through enhanced efficiency, cost-effectiveness, and advancement in patient-centric care.
Tachyon operates at the point of care, eliminating the need for shipping samples or investing in dedicated laboratories and bioinformatics personnel. This decentralised approach streamlines diagnostics and enhances accessibility within clinical settings.
Adaptable Delivering results within minutes to hours, depending on diagnostic depth and requirements, Tachyon significantly reduces turnaround times compared to traditional methods.
Tachyon reduces overall diagnostic costs, making advanced molecular diagnostics more affordable and cost-efficient.
The platform supports the simultaneous analysis of multiple samples, enhancing efficiency and productivity in both clinical and research environments.
Tachyon’s algorithms are easily adaptable, allowing for the seamless expansion into new clinical or research applications. This flexibility ensures the platform remains aligned with medical needs and research requirements.